Madrigal Pharmaceuticals MDGL
$ 346.39
5.21%
Quarterly report 2024-Q3
added 10-31-2024
Madrigal Pharmaceuticals Balance Sheet 2011-2024 | MDGL
Annual Balance Sheet Madrigal Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
16.1 M | -282 M | -35.5 M | - | -46 M | -57.4 M | -149 M | -19.1 M | -30.3 M | -32.2 M | -25.2 M | -69.1 M | -13.5 M |
Long Term Debt |
115 M | 49.3 M | 387 K | - | - | - | - | - | - | 4.61 M | 13.8 M | 4.46 M | 12.4 M |
Long Term Debt Current |
527 K | 602 K | 410 K | 318 K | 315 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
117 M | 49.3 M | 387 K | 468 K | 361 K | - | - | - | - | 4.65 M | 13.9 M | 4.46 M | 12.4 M |
Total Current Liabilities |
119 M | 116 M | 76.8 M | 46.6 M | 25.1 M | 8.44 M | 10.1 M | 4.8 M | 49.3 M | 30.9 M | 32.2 M | 23.5 M | 15.1 M |
Total Liabilities |
235 M | 165 M | 77.2 M | 47 M | 25.5 M | 8.44 M | 10.1 M | 4.8 M | 17.8 M | 35.5 M | 46.1 M | 28 M | 27.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.34 B | -963 M | -667 M | -425 M | -223 M | -139 M | -106 M | -75.3 M | -706 M | -638 M | -551 M | -461 M | -398 M |
Total Assets |
641 M | 363 M | 273 M | 287 M | 442 M | 485 M | 192 M | 41.2 M | 68.2 M | 101 M | 95.2 M | 103 M | 42.3 M |
Cash and Cash Equivalents |
99.9 M | 332 M | 36.3 M | 54 M | 46.7 M | 57.4 M | 149 M | 19.1 M | 306 K | 148 K | 48.5 M | 81.5 M | 30.1 M |
Book Value |
405 M | 197 M | 196 M | 240 M | 417 M | 477 M | 182 M | 36.4 M | 50.4 M | 65.1 M | 49.1 M | 75.1 M | 14.8 M |
Total Shareholders Equity |
405 M | 197 M | 196 M | 240 M | 417 M | 477 M | 182 M | 36.4 M | -48.9 M | 65.1 M | 49.1 M | 75.1 M | 14.8 M |
All numbers in USD currency
Quarterly Balance Sheet Madrigal Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
117 M | 117 M | 116 M | 115 M | 115 M | 99.2 M | 84 M | 49.3 M | 49 M | - | 283 K | 387 K | 491 K | 594 K | 387 K | 468 K | 468 K | 468 K | 468 K | 361 K | 361 K | 361 K | 361 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
118 M | 118 M | 117 M | 117 M | 116 M | 99.2 M | 84 M | 49.3 M | 49.1 M | - | 283 K | 387 K | 491 K | 594 K | 387 K | 468 K | 468 K | 468 K | 468 K | 361 K | 361 K | 361 K | 361 K | - | - | - | - | - | - | - | - | - | - | - | - | - | 11 K | 32 K | 2.33 M | 4.65 M | 4.65 M | 4.65 M | 4.65 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 4.46 M | 4.46 M | 4.46 M | 4.46 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M |
Total Liabilities |
296 M | 243 M | 232 M | 235 M | 216 M | 199 M | 182 M | 165 M | 148 M | - | 76.9 M | 77.2 M | 69.8 M | 57.3 M | 49.2 M | 47 M | 47 M | 47 M | 47 M | 25.5 M | 25.5 M | 25.5 M | 25.5 M | 8.44 M | 8.44 M | 8.44 M | 8.44 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 4.8 M | 4.8 M | 4.8 M | 4.8 M | 49.3 M | 49.3 M | 17.8 M | 17.8 M | 35.5 M | 35.5 M | 35.5 M | 35.5 M | 46.1 M | 46.1 M | 46.1 M | 46.1 M | 28 M | 28 M | 28 M | 28 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.3 M | 4.45 M | - |
Retained Earnings |
-1.74 B | -1.64 B | -1.48 B | -1.34 B | -1.22 B | -1.13 B | -1.04 B | -963 M | -877 M | - | -725 M | -667 M | -603 M | -540 M | -478 M | -425 M | -425 M | -425 M | -425 M | -223 M | -223 M | -223 M | -223 M | -139 M | -139 M | -139 M | -139 M | -106 M | -106 M | -106 M | -106 M | -75.3 M | -75.3 M | -75.3 M | -75.3 M | -48.9 M | -48.9 M | -706 M | -706 M | -638 M | -638 M | -638 M | -638 M | -551 M | -551 M | -551 M | -551 M | -461 M | -461 M | -461 M | -461 M | -398 M | -398 M | -398 M | -398 M |
Total Assets |
1.07 B | 1.1 B | 1.08 B | 641 M | 238 M | 302 M | 332 M | 363 M | 159 M | - | 223 M | 273 M | 305 M | 328 M | 310 M | 287 M | 287 M | 287 M | 287 M | 442 M | 442 M | 442 M | 442 M | 485 M | 485 M | 485 M | 485 M | 192 M | 192 M | 192 M | 192 M | 41.2 M | 41.2 M | 41.2 M | 41.2 M | 364 K | 364 K | 68.2 M | 68.2 M | 101 M | 101 M | 101 M | 101 M | 95.2 M | 95.2 M | 95.2 M | 95.2 M | 103 M | 103 M | 103 M | 103 M | 42.3 M | 42.3 M | 42.3 M | 42.3 M |
Cash and Cash Equivalents |
233 M | 495 M | 623 M | 99.9 M | 62.1 M | 77.2 M | 113 M | 332 M | 59.3 M | 53.3 M | 42.3 M | 36.3 M | 49.2 M | 33.5 M | 44.2 M | 54 M | 54 M | 54 M | 54 M | 46.7 M | 46.7 M | 46.7 M | 46.7 M | 57.4 M | 57.4 M | 57.4 M | 57.4 M | 149 M | 149 M | 149 M | 149 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 306 K | 306 K | 35 M | 35 M | 148 K | 46 M | 46 M | 46 M | 48.5 M | 48.5 M | 48.5 M | 48.5 M | 81.5 M | 81.5 M | 81.5 M | 81.5 M | 30.1 M | 30.1 M | 30.1 M | 30.1 M |
Book Value |
777 M | 857 M | 851 M | 405 M | 22.2 M | 104 M | 150 M | 197 M | 10.7 M | - | 146 M | 196 M | 235 M | 271 M | 261 M | 240 M | 240 M | 240 M | 240 M | 417 M | 417 M | 417 M | 417 M | 477 M | 477 M | 477 M | 477 M | 182 M | 182 M | 182 M | 182 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | -48.9 M | -48.9 M | 50.4 M | 50.4 M | 65.1 M | 65.1 M | 65.1 M | 65.1 M | 49.1 M | 49.1 M | 49.1 M | 49.1 M | 75.1 M | 75.1 M | 75.1 M | 75.1 M | 14.8 M | 14.8 M | 14.8 M | 14.8 M |
Total Shareholders Equity |
777 M | 857 M | 851 M | 405 M | 22.2 M | 104 M | 150 M | 197 M | 10.7 M | 83.5 M | 146 M | 196 M | 235 M | 271 M | 261 M | 240 M | 240 M | 240 M | 240 M | 417 M | 417 M | 417 M | 417 M | 477 M | 477 M | 477 M | 477 M | 182 M | 182 M | 182 M | 182 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | -48.9 M | -48.9 M | 50.4 M | 50.4 M | -42.1 M | 65.1 M | 65.1 M | 65.1 M | 49.1 M | 49.1 M | 49.1 M | 49.1 M | 75.1 M | 75.1 M | 75.1 M | 75.1 M | 14.8 M | 14.8 M | 14.8 M | 14.8 M |
All numbers in USD currency